Financial Survey: Avantor (NYSE:AVTR) versus Bullfrog AI (NASDAQ:BFRG)

Bullfrog AI (NASDAQ:BFRG – Get Free Report) and Avantor (NYSE:AVTR – Get Free Report) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, earnings, analyst recommendations, institutional ownership, risk and valuation.

Profitability

This table compares Bullfrog AI and Avantor’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Bullfrog AI N/A -150.36% -127.98%
Avantor 5.08% 9.79% 4.74%

Earnings and Valuation

This table compares Bullfrog AI and Avantor”s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Bullfrog AI $298,798.00 33.60 -$6.50 million ($0.46) -1.18
Avantor $6.64 billion 1.59 -$530.20 million $0.50 31.09

Bullfrog AI has higher earnings, but lower revenue than Avantor. Bullfrog AI is trading at a lower price-to-earnings ratio than Avantor, indicating that it is currently the more affordable of the two stocks.

Risk and Volatility

Bullfrog AI has a beta of -2.6, indicating that its share price is 360% less volatile than the S&P 500. Comparatively, Avantor has a beta of 0.95, indicating that its share price is 5% less volatile than the S&P 500.

Analyst Ratings

This is a summary of recent recommendations for Bullfrog AI and Avantor, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bullfrog AI 1 1 0 0 1.50
Avantor 1 13 2 0 2.06

Avantor has a consensus target price of $14.77, suggesting a potential downside of 5.01%. Given Avantor’s stronger consensus rating and higher possible upside, analysts plainly believe Avantor is more favorable than Bullfrog AI.

Insider and Institutional Ownership

1.0% of Bullfrog AI shares are held by institutional investors. Comparatively, 95.1% of Avantor shares are held by institutional investors. 14.7% of Bullfrog AI shares are held by insiders. Comparatively, 0.3% of Avantor shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Avantor beats Bullfrog AI on 11 of the 14 factors compared between the two stocks.

About Bullfrog AI

(Get Free Report)

BullFrog AI Holdings, Inc. is a biotechnology-focused artificial intelligence company that develops machine-learning tools for the healthcare and life sciences industries. The company’s work is centered on using artificial intelligence to analyze complex biomedical data and support more efficient approaches to drug development and precision medicine. Its primary technology platform, bfLEAP, is designed to process and interpret large datasets, including genomic and clinical information. BullFrog AI offers data analysis and related services intended to help pharmaceutical companies, biotechnology firms, researchers and other healthcare organizations identify patterns, potential biomarkers, patient subgroups and other insights that may inform therapeutic development.

About Avantor

(Get Free Report)

Avantor, Inc. is a global provider of products and services used in life sciences, advanced technology and applied materials. Its customers include biopharmaceutical and healthcare companies, laboratories, universities and manufacturers. The company supplies chemicals, reagents, laboratory consumables and equipment, as well as materials used in biopharmaceutical production. Avantor also provides services such as procurement, inventory management and support for laboratory and production operations.

Receive News & Ratings for Bullfrog AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bullfrog AI and related companies with MarketBeat.com's FREE daily email newsletter.